This was to protect those adults who have weaker immune systems and are more likely to have poorer outcomes if they get COVID-19.
Roedd hyn er mwyn amddiffyn yr oedolion hynny sydd â systemau imiwnedd gwannach ac sy'n fwy tebygol o gael y canlyniadau gwaethaf os ydynt yn dal COVID-19.